RYTARY
Active substance: LEVODOPA, CARBIDOPA HYDRATE
CAPSULE, EXTENDED RELEASE · LEVODOPA 195 mg/1, CARBIDOPA HYDRATE 48.75 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- LEVODOPA · 195 mg/1
- CARBIDOPA HYDRATE · 48.75 mg/1
Products containing levodopa in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 28 |
|
| EU 7 |
|
Registration
- Registration number
- 64896-663
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 64896-663 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64896-663 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64896-663 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 64896-663 · Verified 2026-10-09 · open in source